Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
NCT04740190
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Glioma
Recurrent Glioblastoma
Poly ADP Ribose Polymerase (PARP) Inhibitor
PTEN Gene Inactivation
IDH Mutation
Interventions
DRUG:
Talazoparib
Sponsor
The University of Hong Kong